Join us:
January 10–12, 2022 in-person in San FranciscoJanuary 17–19, 2022 virtually

Allyson Berent
CSO and COO at Foundation for Angelman Syndrome Therapeutics, GeneTx Biotherapeutics

Agenda Sessions

  • Leveraging platform approaches to gene therapies to accelerate therapeutic development for monogenic diseases

    On Demand